The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis
Identifiers
Identifiers
Date issued
2015-08-20Journal title
European Journal of Pharmacology
Type of content
Artigo
DeCS
apoptosis | líquido sinovial | membrana sinovial | diéster fosfórico hidrolasas | lisofosfolipasa | lisofosfolípidos | artritis experimental | transducción de señales | artritis | artritis reumatoide | ARN mensajeroMeSH
Apoptosis | Synoviocytes | Lysophospholipase | Synovial Fluid | Arthritis, Experimental | Arthritis | Synovial Membrane | Signal Transduction | Phosphoric Diester Hydrolases | Conflict of Interest | Arthritis, Rheumatoid | RNA, Messenger | LysophospholipidsAbstract
[EN] Lysophosphatidicacid (LPA )is a phospholipid that i smainly produced by the hydrolysis of lysopho- sphatidylcholine (LPC) by lysophospholipase D, which is also called autotaxin (ATX).LPA interacts with specific G-protein coupled receptors and is involved in the regulation of cellular survival, proliferation,differentiation and motility . LPA also has roles in several pathological disorders, such as cancer and pulmonary, dermal and renal fibrosis. The involvement of the ATX–LPA pathway has recently been demonstrated in inflammatory responses and apoptosis of fibroblast like synoviocytes (FLS) from patients with rheumatoid arthritis and during the development of experimental arthritis.This review summarises the current literature of the ATX–LPA pathway in rheumatoid arthritis.